$0.38-0.03|(-7.58%)
52W H: 0.652W L: 0.2181Beta: 1.19

About Milestone Scientific Inc

Frequently Asked Questions

What is the 52-week range for MLSS?

The 52-week high is $0.6 and the 52-week low is $0.2181.

What is the P/E ratio for MLSS?

The P/E ratio data is currently unavailable.

What is the dividend yield for MLSS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -149.08%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -43.98%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 7.63.

Analyst Recommendation Trends

Wall Street analyst consensus for MLSS over the last few months:

2026-09-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0

Latest MLSS News

Friday's pre-market session: top gainers and losers

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

ChartMill10/2/2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 56.7% to $0.16 during Friday's pre-market session. Stablecoin Development (AMEX:SDEV) stock rose 30.86% to $4.79. The company's market cap stands at

Benzinga10/2/2026

Why Synaptics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Synaptics surged 14.5% after amending its $123/share cash buyout by onsemi; AMOD led gainers, while WCT fell 20.3% premarket.

Benzinga10/2/2026

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence ExpandROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress in building a structured and scalable growth platform for its CompuFlo® medical business. “We are building CompuFlo into a scalable medi

Yahoo9/29/2026

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. Evotec (NASDAQ:EVO) stock rose 8.44% to

Benzinga9/21/2026

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategyROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D., Medical Director of Pain and Spine Specialists, and Pain and Spine Specialists have joined Milestone Scientific as a development partner and member of the Compa

Yahoo9/16/2026

Milestone Scientific Files Prospectus To Offer Securities Up To $45M

-SEC Filing

Benzinga9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to MLSS:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2025-10-24BP4 S.r.l.-100,000$0.4398$43,980
2025-10-23BP4 S.r.l.-80,000$0.4302$34,416
2025-10-22BP4 S.r.l.-14,427$0.4497$6,488
2025-10-21BP4 S.r.l.-40,000$0.4398$17,592
2025-10-20BP4 S.r.l.-24,034$0.4527$10,880
2025-10-14BP4 S.r.l.-30,000$0.5395$16,185
2025-10-13BP4 S.r.l.-10,000$0.55$5,500
2025-10-10BP4 S.r.l.-10,158$0.5501$5,588
2025-10-08BP4 S.r.l.-30,000$0.465$13,950
2025-10-07BP4 S.r.l.-10,000$0.45$4,500
2025-10-03BP4 S.r.l.-10,000$0.45$4,500
2025-10-03BP4 S.r.l.-9,210$0.4491$4,136